Targeting the cytokines expressed by foamy macrophages, i.e., osteopontin, using iron oxide NPs decorated with anti-osteopontin mAb could enhance the targeting of atherosclerosis plaques [231]. The gene discussed is SPP1; the disease is atherosclerosis.